About Grupo Cooperativo de Hemopatías Malignas
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Grupo Cooperativo de Hemopatías Malignas
During the past decade, Grupo Cooperativo de Hemopatías Malignas conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Grupo Cooperativo de Hemopatías Malignas
According to Clinical.Site data, the most researched conditions in "Grupo Cooperativo de Hemopatías Malignas" are
"Acute Myeloid Leukemia" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)" (1 trials), "COVID-19" (1 trials) and "Chronic Myeloid Leukaemia Recurrent" (1 trials). Many other conditions were trialed in "Grupo Cooperativo de Hemopatías Malignas" in a lesser frequency.
Clinical Trials Intervention Types at Grupo Cooperativo de Hemopatías Malignas
Most popular intervention types in "Grupo Cooperativo de Hemopatías Malignas" are "Drug" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-azacitidine" (1 trials), "Daratumumab Only Product in Parenteral Dose Form" (1 trials), "Ibrutinib" (1 trials), "Myeloid mutations measurement" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Grupo Cooperativo de Hemopatías Malignas
The vast majority of trials in "Grupo Cooperativo de Hemopatías Malignas" are
5 trials for "All" genders.
Clinical Trials Status at Grupo Cooperativo de Hemopatías Malignas
Currently, there are NaN active trials in "Grupo Cooperativo de Hemopatías Malignas".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Grupo Cooperativo de Hemopatías Malignas,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Grupo Cooperativo de Hemopatías Malignas, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".